Brief: Teleflex Enrolls First Patient In Dubstent Diabetes Trial Targeting Improved PCI Outcomes For Diabetic Patients
11/09/2025 11:32
Sept 11 (Reuters) - Teleflex Inc TFX.N: FIRST PATIENT ENROLLED IN DUBSTENT DIABETES TRIAL: TARGETING IMPROVED PCI OUTCOMES FOR DIABETIC PATIENTS Source text: ID:nGNX87ykH8 Further company coverage: TFX.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Teleflex Incorporated
See all newsBrief: UK's CMA Issues Invitation to Comment on Intersurgical-Teleflex Transaction
Competition and Mkts - Merger Update: Intersurgical / Teleflex
Teleflex Incorporated reports results for the quarter ended June 30 - Earnings Summary
Teleflex Q2 revenue rises 29%, beats analyst estimates
US FDA approves first freeze-dried plasma product (updated)